Introduction
Protein kinase (PK)Cy, a Ca þ þ -independent PKC isoenzyme, selectively expressed in T cells, has been previously shown to play an essential role in the TCRtriggered activation of NF-kB, resulting in proliferation of mature T cells Lin et al., 2000; Sun et al., 2000) . Moreover, recent observations in PKCy À/À mice suggested that PKCy is dispensable for both thymocyte differentiation and TCR-induced NF-kB activation in immature thymocytes (Sun et al., 2000) . In previous reports, PKCy was found to be constitutively bound to vav in thymocytes and to mediate vav-dependent intrathymic selection process (Kong et al., 1998; Villalba et al., 2000) . Finally, expression of CD25 and CD69 has been shown to be dependent on the function of PKCy in both thymocytes and mature T cells in in vivo and in vitro experimental systems (Szamel et al., 1998; Sun et al., 2000) .
Several studies underlined the key role of NF-kB activation in regulating the molecular mechanisms involved in T-cell proliferation and/or neoplastic transformation (Carrasco et al., 1996; Rayet and Gelinas, 1999) . Moreover, we previously showed that T-cell leukemia/lymphoma that arises in transgenic mice, expressing an lck-driven constitutively active intracellular domain of Notch3 (Notch3-IC), displays a persistent high expression of pre-T-cell receptor (TCR) pTa chain and a IkBa-dependent constitutive activation of NF-kB (Bellavia et al., 2000) .
These observations suggest that Notch3-induced tumors provide an aberrant T-cell developmental model of leukemogenesis. Indeed, despite the persistent expression of pTa/pre-TCR, preleukemic thymocytes as well as lymphoma cells display features characteristic of cells undergoing intrathymic selection process and/or peripheral T-cell activation (i.e. high expression of CD69, increased expression of CD3, CD25 and TCRb chain) (Bellavia et al., 2000) . We earlier showed that Notch3 is ordinarily expressed in immature thymocytes (Felli et al., 1999) , at or around a critical developmental stage, known as b-selection, that is mediated by the pre-TCR signaling (von Boehmer and Fehling, 1997) . Pre-TCR signaling has recently been shown to lead to the activation of NF-kB, independently on ligand binding (Aifantis et al., 2001) , and active NF-kB provides a selective survival signal for late CD4 À
CD8
À double negative thymocytes that have undergone productive bselection (Voll et al., 2000) . However, how pre-TCR signaling activates NF-kB and which adaptor molecules can have a role in mediating such an activation need to be fully elucidated.
Together, these observations prompted us to study a possible role of PKCy in mediating the NF-kB constitutive activation we observed in premalignant thymocytes and T lymphoma cells of Notch3-IC transgenic mice and the possible relationship between PKCy and the increased pTa/pre-TCR signaling during the T-cell leukemogenic process.
We report here that PKCy is a downstream target of Notch3 signaling and it is necessary to Notch3-dependent triggering of NF-kB. Moreover, we demonstrate that PKCy kinase function and membrane translocation require a functional pre-TCR, positioning, for the first time, PKCy downstream of the pre-TCR signaling. Finally, by generating Notch3-IC/PKCy À/À double-mutant mice, we show that deletion of PKCy in Notch3-IC transgenic mice reduces the incidence of leukemia, correlating with decreased NF-kB, thus suggesting that PKCy is an important mediator of the Notch3 lymphomagenic potential.
Results

PKCy kinase activity is induced by constitutively active Notch3 and requires pTa/pre-TCR
We previously demonstrated that Notch3-IC transgenic thymocytes display a dysregulated high expression of pTa pre-TCR chain and constitutive NF-kB activity (Bellavia et al., 2000) . It has recently been shown that pre-TCR signaling leads to the activation of NF-kB, independently of ligand binding (Aifantis et al., 2001) , while TCR-triggered T-cell activation is associated with the translocation of PKCy to the cell membrane (Monks et al., 1997) , finally resulting in NF-kB activation. Thus, PKCy may represent a possible integrator of signal transduction pathways from activated Notch3, via pre-TCR signaling, to NF-kB activation. In order to test this hypothesis, we firstly analysed the activity of PKCy in wild-type (wt) and Notch-3IC transgenic mice. Figure 1a shows that PKCy kinase activity is clearly enhanced in transgenic with respect to wt thymocytes and the addition of TPA in the assay, while significantly increasing kinase activity of thymocytes from wt mice, did not cause further increase in the substrate phosphorylation by Notch3-IC transgenic cell extracts. This observation suggests that Notch3 signaling activation itself was able to fully enhance PKCy kinase activity.
To study the possible relationship between the constitutive activation of PKCy kinase activity and the pTa/pre-TCR overexpression in Notch3-IC transgenic thymocytes, we tested the PKCy kinase activity in the presence or the absence of pTa/pre-TCR. Figure 1b shows that PKCy was able to phosphorylate, at a higher level, the specific substrate Myelin Basic Protein (MBP) in transgenic Notch3-IC in comparison to wt thymocytes. In contrast, by using thymocytes obtained from the previously described Notch3-IC/pTa À/À doublemutant mice, lacking a functional pTa/pre-TCR (Bellavia et al., 2002) , we demonstrated that PKCy kinase activity decreased to the level observed in wt thymocytes. Notably, Western blot analysis of the expression levels of PKCy protein (Figure 1c ) in thymocytes of both transgenic Notch3-IC and double-mutant Notch3-IC/pTa À/À mice suggests that the modification of PKCy activity is not accounted for by changes of PKCy protein levels.
PKCy translocation to the cell membrane is increased in Notch3-IC transgenic thymocytes and depends on the presence of pTa/pre-TCR It has been previously shown that ligand-dependent triggering of TCR is associated with membrane translocation of PKCy, which colocalizes with the TCR/CD3 complex and requires phosphorylation by and physical association with p56 Lck Src kinase (Monks et al., 1997; Liu et al., 2000) . In contrast, pre-TCR has been shown to translocate and colocalize with the p56
Lck into glycolipid-enriched membrane domains (rafts), apparently without any need for ligation (Saint-Ruf et al., 2000) .
Together, these observations prompted us to study whether the persistent high expression of pTa/pre-TCR, observed in Notch3-IC transgenic thymocytes, was also associated to sustained PKCy translocation to the membrane. Figure 2a shows that a higher amount of PKCy translocates to the membrane of Notch3-IC transgenic with respect to wt thymocytes, and that such a translocation depends on the presence of pTa. Indeed, the levels of membrane-associated PKCy decreased in Notch3-IC/pTa À/À double-mutant thymocytes below the wt levels. Immunofluorescence staining further supports the observation that PKCy membrane localization depends on the presence of pTa ( Figure 2c , lower panel). Figure 2b and c (upper panel) show that the levels of membrane-associated p56
Lck remain unchanged, according to the previously shown ability of Lck to be constitutively associated to the cell membrane of T cells (Hardwick and Sefton, 1997) . Notably, the panel b may represent the internal control of panel a, since the same blot was reprobed with anti-Lck. Conversely, by immunoprecipitation experiment we observed that Lck/PKCy direct interaction was present at a higher level in Notch3-IC with respect to the wt, being absent in Notch3-IC/pTa À/À double-mutant thymocytes (Figure 2d, upper panel) .
It is known that the catalytic activity of Lck is greatly influenced by its tyrosine phosphorylation status (Hardwick and Sefton, 1997) . Accordingly, we observed ( Figure 2d, Finally, double immunofluorescence staining shows that PKCy and pTa colocalize to the cell membrane and are expressed at higher levels in thymocytes from transgenic ( Figure 2e ) with respect to wt mice. Figure 2f shows the absence of crossdetection by secondary antibodies utilized in the double staining showed in Figure 2e .
Virtually 100% of thymocytes in N3-IC mice express the pre-TCR in the plasma membrane in contrast with wt animals in which surface pre-TCR is detectable on a minute fraction, and the increase in PKCy membrane translocation was suggestive of a role of the pre-TCR in inducing such effect.
Together, these observations suggest that the constitutive activation of Notch3 signaling, in the presence of an intact pre-TCR, by favoring activation of Lck and PKCy/p56
Lck interaction, increases the recruitment of PKCy to the cell membrane, thus possibly favoring the activation of PKCy, the persistence of pTa/pre-TCR to the cell membrane and their downstream targets. Lck . (e) Cytospin preparations of thymocytes from WT and N3-IC mice immunostained with anti-pTa (red) and anti-PKCy (green) mAbs, each followed, respectively, by a Texas-RED(TR)-conjugated and an FITC-conjugated anti-mouse (GAM) secondary antibody. (f) Cytospin preparations of thymocytes from N3-IC mice immunostained with anti-pTa followed sequentially by a Texas-RED(TR)-conjugated and an FITC-conjugated anti-mouse (GAM) secondary antibody PKCy is required to enhance NF-kB activation observed in Notch3-IC transgenic mice via activation of the IkB kinase (IKK) complex In order to investigate the possible role of PKCy in mediating Notch3-dependent NF-kB constitutive activation, Notch3-IC/PKCy À/À double-mutant mice were generated, by intercrossing Notch3-IC transgenic and previously described PKCy À/À mice (Sun et al., 2000) . Analysis of the immunophenotype of the double-mutant mice was performed at different ages. The distribution of the thymocyte subpopulations revealed no striking differences with respect to CD4-and/or CD8-expressing cells, as observed in PKCy À/À mice (Sun et al., 2000) , in younger Notch3-IC transgenic (Bellavia et al., 2000) and in adult Notch3-IC/pTa À/À double-mutant mice ( Figure 3a , upper panels). In contrast, in the absence of PKCy, the significantly increased expression of CD69, observed in Notch3-IC mice, appeared to be restored to the control levels in double-mutant mice ( Figure 3a , lower panels), in agreement with the previously suggested dependence of CD69 expression on PKCy function (Sun et al., 2000) . Interestingly, the expression of CD69 was restored to the control levels also in Notch3-IC/Pta À/À thymocytes, further supporting a possible role of pre-TCR in sustaining PKCy function (Figure 3 , lower panel a).
The pattern of the NF-kB activity was monitored by electrophoretic mobility shift assay (EMSA) of nuclear extract from freshly isolated unfractionated thymocytes, obtained from 4-week-old mice. When compared to Notch3-IC transgenic mice, nuclear extracts of thymocytes from double-mutant Notch3-IC/PKCy À/À mice showed a significant reduction of the NF-kB/DNA complex (Figure 3b , lower arrow), mostly composed of p50 and p65 subunits (Figure 3b, upper arrows) .
In resting cells, the NF-kB dimer p50/p65 is sequestered in the cytosol, by binding to the inhibitor of NF-kB, IkBa and its nuclear translocation can be induced by a wide variety of stimuli, which activate the IKK complex, thus allowing the phosphorylation and degradation of IkBa (reviewed in Dixit and Mak, 2002) .
Consistently with our previous observation that the constitutive NF-kB activation observed in Notch3-IC transgenic mice thymocytes correlated with increased IKK-dependent degradation of IkBa (Bellavia et al., 2000) , we hypothesized a possible impairment of the IKK complex kinase activity in PKCy mutant mice. IKK complex includes two catalytic subunits, IKKa and b and the regulatory subunit IKKg (Israel, 2000) and it has been previously shown that PKCy selectively activates IKKb kinase; thus, we decided to determine the IKK complex kinase activity by IKKb selective immunoprecipitation followed by an in vitro kinase assay using GST-IkBa as a substrate. As shown in Figure 3c (upper panel), we observed a significant reduction of IKKb kinase activity in double-mutant Notch3-IC/PKCy À/À mice, when compared to thymocytes of transgenic Notch3-IC mice that instead display high levels of IKKb kinase activity associated with the contitutively high NF-kB activity. The lower panel of Figure 3c shows that the protein levels of IKKb are comparable in different thymocyte samples, thus excluding the assumption that the decreased IKKb kinase activity observed in double-mutant mice was due to a decrease of protein levels.
Intact pre-TCR is required to allow PKCy membrane translocation and functional cooperation of Notch3 and PKCy for NF-kB transactivation Overall, the above-described results suggest that the PKCy increased activity observed in Notch3-IC mice depends on the presence of an intact pre-TCR and that it is required to fully enhance Notch3-dependent NF-kB activation.
In order to directly link PKCy membrane translocation and function to the presence of an intact pre-TCR, we performed experiments in pre-TCR-deficient and pre-TCR-competent cell lines. To this purpose, we utilized the TCRb-deficient cell line SCIET.27 (lacking a functional pre-TCR expression) and the TCRbtransfected daughter cell line SCB.29 (expressing a signaling-competent pre-TCR on the cell surface), derived from severe-combined immunodeficient (SCID) thymocytes (Aifantis et al., 2001) . Figure 4a shows that a higher amount of PKCy translocates to the membrane of SCB.29 with respect to SCIET.27 cells. Indeed, despite a slight increase (1.5-fold) in cytosolic fraction, a significantly higher increase (eight-fold) of PKCy expression levels in membrane fraction of SCB.29 cells with respect to SCIET.27 cells was observed at the densitometric analysis. The localization of PKCy preferentially into the rafts of SCB.29 cells with respect to SCIET.27, when compared to the similar distribution of Lck in both the cell lines (Figure 4a middle and lower panels, respectively), further confirms the requirement of an intact pre-TCR for the membrane translocation of PKCy. Figure 4b shows the densitometric analysis of PKCy detected in membrane and cytosolic fractions of SCIET.27 and SCB.29 cells (left panel) and the membrane to total distribution of PKCy expression levels in both the cell lines (right panel).
In order to confirm the agonistic effect between Notch3 and PKCy and to directly demonstrate the requirement of both a functional pre-TCR and PKCy to obtain a full NF-kB transactivation, we cotransfected SCB.29 and SCIET.27 cell lines with a Notch3-IC expression vector, together with a NF-kB-luciferase reporter plasmid, in the presence or in the absence of a mutant dominant negative (DN) PKCy (DN-PKCy).
NF-kB-luciferase activity was significantly reduced by cotransfection of DN-PKCy and Notch3-IC in pre-TCR competent SCB.29, but not in pre-TCR-deficient SCIET.27 cells (Figure 4c) , consistently with the requirement of an intact pre-TCR for the Notch3-dependent increase of PKCy activity, necessary for the full activation of NF-kB. 
PKCy contributes to the development of Notch3-induced T-cell leukemogenesis
We have previously shown that the activation of proliferative and survival signals by Notch3 (e.g. pTa/ preTCR-and NF-kB-dependent) plays a crucial role in sustaining the development and the proliferation of Notch3-IC lymphoma cells (Bellavia et al., 2000) . Therefore, we further investigated the relationship between Notch3, NF-kB activation, PKCy and T-cell leukemogenesis. While by 16 weeks of age 95% of Notch3-IC transgenic mice were dead, displaying phenotypic features of multicentric T-cell lymphoblastic lymphoma (Bellavia et al., 2000) , 65% of a group of 50 Notch3-IC/PKCy À/À double-mutant mice were still alive past 20 weeks of age (Figure 5a ). Among the surviving animals, only 40% displayed signs of lymphoproliferative disease at autopsy (Figure 5b ), such as enlargement of the upper mediastinum and a two-to three-fold increase in the size and weight of the spleen. The follow up of 28 double-mutant mice surviving beyond the age of 20 weeks showed that 50% die spontaneously over 30 weeks of age, while at the age of 50 weeks only 20% of mice survive. These results strongly suggest that a consistently lower number of Notch3-IC/PKCy À/À double-mutant with respect to Notch3-IC transgenic mice develop the lymphoproliferative disease with significantly delayed kinetics, thus supporting the idea that PKCy is an important mediator of the lymphomagenic potential of Notch3, possibly correlating with the NF-kB activation status. Accordingly, Figure 5c shows that EMSA of CD8 þ selected thymocyte nuclear extracts from 10-week-old Notch3-IC/PKCy À/À doublemutant mice display lower levels of NF-kB/DNA complexes when compared to Notch3-IC transgenic ones. CD8 þ selected thymocytes were utilized at this age since we previously reported that T-cell lymphomas developing in most of the Notch3-IC transgenic mice are represented by immature CD8 þ and/or CD4 þ CD8 þ double positive (DP) cells (Bellavia et al., 2000) . Purified populations contained >90% of CD8 þ and DP cells. Interestingly, the difference of NF-kB/DNA complexes was mostly observed at the level of p65 subunit compared to p50 subunit ones. Since p50 homodimers have been reported to be transcriptional inhibitors, the prevailing presence of p65 in the composition of the NFkB complex in Notch3-IC transgenic with respect to Notch3-IC/PKCy À/À double-mutant thymocytes may explain the lower incidence of leukemia in doublemutant mice.
The results described above would suggest that PKCy is necessary for full activation of NF-kB and that such an activation plays a major role in the development of leukemia. However, our previous observation that virtually all the Notch3-IC/pTa À/À double-mutant mice are leukemia free (Bellavia et al., 2002) suggests that PKCy does not fully mediate the pre-TCR-dependent leukemogenic activity or that, although NF-kB constitutive activation plays a major role in sustaining antiapoptotic and proproliferative signals, leukemogenesis may require the triggering of additional pre-TCRdependent pathways.
In this regard, we recently demonstrated that pre-TCR-mediated Notch3-dependent repression of the oncosuppressor transcription factor E2A correlates with T-cell lymphoma development in Notch3-IC transgenic mice, instead being restored in thymocytes from Notch3-IC/pTa À/À double-mutant mice, that do not develop leukemia (Talora et al., 2003) . For this reason, we compared E2A DNA-binding activity in CD8 þ selected thymocytes from wt, Notch3-IC transgenic, Notch3-IC/PKCy À/À and Notch3-IC/pTa À/À double-mutant mice. Figure 5d shows that E2A DNA binding is not restored in thymocytes from Notch3-IC/PKCy À/À mice, as instead we observed in Notch3-IC/pTa À/À thymocytes (Talora et al., 2003) , suggesting that the lower efficiency of PKCy mutation in protecting from leukemia, when compared to pTa mutation, may be related to the lack of restoring E2A oncosuppressor function, whose repression appears to be specifically targeted by pre-TCR during Notch3-induced T-cell leukemogenesis.
Discussion
Overall, we provide genetic and biochemical evidence that PKCy is a downstream target of Notch3 activated signaling and that its membrane translocation and its activation require a functional pre-TCR in order to trigger NF-kB activation. These findings highlight a crucial role for PKCy in mediating the constitutive activation of NF-kB induced by the Notch3/pTa crosstalk. To this end, PKCy is required for Notch3-dependent activation of the IKK complex. Therefore, we provide the first direct evidence, to our knowledge, that pre-TCR is able to regulate PKCy membrane translocation and activity, a property so far only described for a/b and g/d TCR Cipriani et al., 2002) . Notably, such a pre-TCR activity is unveiled by Notch3 activation. These observations are consistent with the previously shown ability of pre-TCR to colocalize with the p56
Lck Src kinase into glycolipid-enriched membrane domains (rafts), apparently without any need for ligand (SaintRuf et al., 2000) . On the other hand, p56 lck , known to induce tyrosine phosphorylation of PKCy, may in turn modulate the physiological functions of PKCy during TCR-induced T-cell activation (Liu et al., 2000) , suggesting that pre-TCR membrane localization and PKCy activation are regulated by the same kinase (i.e. Lck). Further support to the involvement of Notch in Lck signaling is given by the recent observation that ectopic expression of constitutively active Notch1 results in increased phosphorylation of Lck and, more strikingly, that Notch1 physically interact with p56 lck (Sade et al., 2003) . Accordingly with these data, we observed increased phosphorylation of Lck in Notch3-IC transgenic thymocytes. Moreover, while we were unable to detect physical interaction between Notch3 and Lck, we observed an increased interaction between Lck and PKCy, in Notch3-IC transgenic thymocytes, that may justify the increased membrane translocation of PKCy and, subsequently, the activation of downstream target (i.e. NF-kB).
The colocalization of PKCy and pTa we observed in transgenic thymocytes has not been previously described, to our knowledge. Such a colocalization might represent the consequence of the increased interaction between activated Lck and PKCy and may be in turn responsible for the increased persistence of pTa on the cell membrane of transgenic thymocytes. Our recent observation of the transcriptional activation of pTa gene by constitutively active Notch3-IC (Talora et al., 2003) adds a further piece to a hypothetical model we propose here in which Notch3-IC-induced enhanced pre-TCR expression would in turn recruit PKCy to the cell membrane, via activation of Lck, thereby triggering a signaling cascade issuing in IKK-dependent activation of NF-kB that, as a tumor progression factor, would significantly contribute to lymphoma cell proliferation.
Moreover, the present paper, by confirming a PKCyindependent inhibition of E2A, which is instead specifically dependent upon some distinct pre-TCRtriggered signal, further highlights the importance of combined expression of Notch3 and pTa in sustaining the T-cell leukemogenesis (Bellavia et al., 2002) , possibly by inhibiting the oncosuppressor E2A (Talora et al., 2003) .
It is noteworthy that we observed that in Notch3-IC/ PKCy À/À double-mutant mice the reduction of NF-kB activation correlates with a decreased incidence of leukemia. This paper therefore sustains the role of PKCy in mediating the NF-kB constitutive activation observed in Notch3-IC mice, which certainly plays a key role in sustaining T-cell proliferation, also suggesting that PKCy contributes to the development of T-cell lymphomas.
To this purpose, it is important to note that common features of human T-cell acute lymphoblastic leukemias have previously shown to be both combined expression of Notch3 and pTa (Bellavia et al., 2002) , and constitutively activated NF-kB (Kordes et al., 2000) . Therefore, our data, together with the observations that PKCy provides a survival signal for leukemic T cells (Villalba and Altman, 2002) , suggest that PKCy may integrate multiple events that collaborate with each other to elicit T-cell neoplastic transformation and tumor progression.
Materials and methods
Mice
The generation and typing of Notch3-IC transgenic mouse (Bellavia et al., 2000) , Notch3-IC/pTa 
PKCy immunoprecipitation and kinase assay
For kinase assay, thymocytes were lysed in buffer containing 20 mM Tris pH 7.6, and 0.5% NP-40, 0.25 M NaCl, 3 M EDTA, 3 M EGTA, 20 mM NaF, 2 mM Na 3 VO 4 , 1 mM dithiothreitol, 100 mg/ml leupeptin, 20 mg/ml aprotinin and 1 mM phenylmethylsulfonyl fluoride (PMSF). After centrifugation, PKCy was immunoprecipitated with anti-PKCy (Transduction laboratories) conjugated to protein A/G plus-agarose (Santa Cruz Biotechnology, Inc.) and the kinase assay was performed as previously described (Monks et al., 1997) .
To directly assay PKCy kinase activity on a specific substrate, thymocytes were lysed and processed for radioactive kinase assay according to the manufacturer's protocol (Upstate Biotechnology).
The phosphorylation status of MBP substrate was assessed by immunoblotting with anti-phospho MBP antibody (clone P12, Upstate Biotechnology). Immunoreactive bands were visualized by enhanced chemiluminescence (ECL, Pierce). The same whole-cell extracts were processed by 10% SDS-PAGE to assay total PKCy level, and protein loading was monitored by using b-tubulin (Santa Cruz Biotechnology, Inc.).
LCK immunoprecipitation
Freshly isolated thymocytes were lysed in 20 mM Tris-HCl pH 7.5, 150 mM NaCl, 1% Triton X-100, 1 mM EDTA pH 8.0, 30 mM NaF, 2 mM Na-pirophosphate, 1 mM Na-orthovanadate (Na 3 VO 4 ). In all, 300 mg of total proteins in lysates from each sample were immunoprecipitated with mouse monoclonal anti-p56
Lck conjugated to protein G-agarose (sc433, Santa Cruz Biotechnology, Inc.). For immunoblotting, proteins were resolved by 10% SDS-PAGE and blotted onto nitrocellulose membrane. The blot was incubated with a mouse antibody directed against PKCy (610089, Transduction Laboratories). The levels of phospho-Lck in the immunoprecipitated samples were detected using a p-Tyr biotinylated antibody (RC20, BD Biosciences). The blot was reprobed with anti-p56
Lck (sc-433, Santa Cruz Biotechnology, Inc.).
IKKb kinase assay
Thymocytes were lysed and immunoprecipitated with antiIKKb (H4) conjugated to protein A/G plus-agarose (sc-8014, Santa Cruz Biotechnology, Inc.). The immunopellets were incubated with a kinase buffer master mix supplemented with 20 mM ATP, 5 mCi of [g-32 P]ATP and 3 mg of GST-IkBa substrate (Santa Cruz Biotechnology) at 301C for 30 min. The samples were analysed by 10% SDS-PAGE and the phosphorylation status of GST-IkBa substrate was detected by autoradiography.
Subcellular fractionation
Subcellular fractionation of freshly isolated thymocytes was performed according to the technique described elsewhere . In total, 50 mg of protein extract from each sample was subjected to SDS/PAGE.
Rafts isolation
Sucrose gradient fractionation was performed as previously described (Montixi et al., 1998) . Briefly after solubilization, proteins from the different samples were mixed with 1 ml 80% sucrose prepared in buffer A (25 mM Tris-HCl pH 7.5, 150 mM NaCl, 5 mM EDTA) and carefully overlined with two phases of 2 ml 30% sucrose and 1 ml 5% sucrose, respectively. After centrifugation at 48 000 r.p.m. for 18 h in an SW41 rotor (Beckman Instruments Inc.), 0.4 ml fractions were collected and numbered from the top of the gradient. The samples were then precipitated in trichloroacetic acid (TCA). Rafts fractions (from 3 to 5) as well as loading zone fractions (from 9 to 12) were pooled and an equal amount of proteins recovered was resolved by SDS-PAGE in reducing 8% gel, transferred to nitrocellulose membranes and sequentially blotted with antiPKCy and anti-Lck monoclonal antibodies (mAbs).
Flow cytometry (FCA)
Freshly isolated cells from thymuses and spleens were prepared and stained as previously described (Maroder et al., 1996) . Stained cells were analysed on FACScan (Becton Dickinson), using Cell Quest software (Becton Dickinson), with at least 1 Â 10 4 events scored. Positive cells were defined after forwardand side-scatter gating to exclude dead cells from the analysis.
All the monoclonal antibodies used were directly conjugated to fluorescein isothiocyanate (FITC) or phycoeritrin (PE). The mAbs used were against: CD4 (H-129.19), CD8a (53-6,7), CD25 (IL-2a chain, 7D4), CD3 (e chain:145-2C11), TCR b chain (H57-597), CD69 (H1.2F3) (Pharmigen-Becton Dickinson Company). PE-and FITC-conjugated rat and hamster IgG (Pharmingen, San Diego, CA, USA) were used as a control for immunofluorescence.
Cell lines
Transient transfection experiments were performed using pre-T-cell lines -SCIET.27 (TCRb-deficient cell line), and -SCB.29 cell line (TCRb-transfected expressing a signaling-competent pre-TCR on the cell surface), grown in RPMI supplemented with 10% FBS and 0.28 mM b-mercaptoethanol (Aifantis et al., 2001 ).
Plasmids, cell transfection and luciferase assay
Transfection of pre-T cell lines (SCB.29 and SCIET.27) were performed by Lipofectamine 2000 kit (Invitrogen) according to the manufacturer's instructions. Experiments were performed by cotransfecting a NF-kB-reporter plasmid (0.5-mg) (pNF-kB-luc, Clontech) in the presence or absence of the expression vector CMV-Notch3IC (1.5-mg) (Bellavia et al., 2000) and/or of DN-PKCy (1.5-mg), kindly provided by Dr Baier (Villunger et al., 1999) . Renilla luciferase reporter vector pTK-Renilla-Luc (0.5 ng) was also incorporated into each transfection (Promega, Madison, WI, USA). At 24 h posttransfection, the cells were lysed in a reporter lysis buffer (Passive Lysis Buffer; Promega) at 120-ml/well.
Firefly-and pRL-TK-derived Renilla luciferase activities were measured in each sample with the Dual luciferase Assay System (Promega) using a Model TD-20/30 luminometer (Turner Designs). Light emission was measured for 10 s after injection. The NF-kB-specific luciferase activity was determined in triplicate samples and was normalized on the Renilla luciferase activity. Data were expressed as means7s.d. of at least three independent experiments.
EMSA
Nuclear and whole-cell extracts were prepared as previously described (Bellavia et al., 2000; Bain et al., 2001) . Unfractionated thymocytes were used when young mice were examined. When older (>7 weeks) mice were analysed, nuclear and whole-cell extracts were obtained from positively selected CD8 þ thymocytes. Purified populations contained >90% of CD8 þ and DP cells. A [ 32 P]dATP-labeled double-stranded oligonucleotide spanning the NF-kB site (5 0 -GATCCAACGG CAGGGGAATTCCCCTCTCCTTA-3 0 ) was incubated with nuclear extracts at RT for 20 min with 2 mg of poly(dI-dC) in 50 mM NaCl, 10 mM Tris pH 7.5, 1 mM DTT and 20% glycerol. Band shifts were resolved on nondenaturing 4% polyacrylamide gel. Antibodies against p50 (sc114), p65 (sc7151) (Santa Cruz Biotechnology Inc.) were incubated for 20 min at RT before the binding reaction. E2A DNA-binding activity was performed as previously described (Talora et al., 2003) .
Immunofluorescence
Cytospin preparations of thymocytes from wt, Notch3-IC transgenic and double-mutant Notch3-IC/pTa À/À mice were immunostained with anti-PKCy (P15120, Transduction Laboratories) or anti-p56 LCK (sc-433, SantaCruz Biotech) mAbs, followed, respectively, by Texas-RED-conjugated and by a FITC-conjugated secondary antibodies. For two-color immunostaining, the slides were sequentially stained, for 1 h at RT, with a mouse anti-pTa mAb, kindly provided by H von Bohemer (Aifantis et al., 1998) , followed by a Texas-REDconjugated goat anti-mouse secondary antibody (Jackson Immunoresearch Lab). After washing, an anti-PKCy (610090, Transduction laboratories) was added and followed by an FITC-conjugated secondary antibody (Jackson Immunoresearch Lab). Absence of crossdetection by secondary antibodies utilized in double staining was carefully controlled by preparing control slides subjected to staining with primary antibody followed sequentially by both the secondary antibodies. All slides were examined by confocal microscopy.
